Literature DB >> 23569313

Vemurafenib as neoadjuvant treatment for unresectable regional metastatic melanoma.

Karlijn Koers1, Anne Brecht Francken, John B A G Haanen, Leonie A E Woerdeman, Jos A van der Hage.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23569313     DOI: 10.1200/JCO.2012.45.3845

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  15 in total

Review 1.  Surgical resection of metastatic melanoma in the era of immunotherapy and targeted therapy.

Authors:  Richard Tyrell; Camila Antia; Sharon Stanley; Gary B Deutsch
Journal:  Melanoma Manag       Date:  2017-02-21

Review 2.  Adjuvant treatment for stage III melanoma in the era of targeted medicine and immunotherapy.

Authors:  Eytan Ben-Ami; Jacob Schachter
Journal:  Melanoma Manag       Date:  2016-05-25

Review 3.  New options for the adjuvant treatment of cutaneous melanoma?

Authors:  Amy M Weise; Lawrence E Flaherty
Journal:  Curr Oncol Rep       Date:  2014-11       Impact factor: 5.075

4.  Neoadjuvant BRAF-targeted therapy in regionally advanced and oligometastatic melanoma.

Authors:  Zeynep Eroglu; Jennifer Eatrides; Syeda Mahrukh Hussnain Naqvi; Youngchul Kim; Jeani Rich; Nalan Akgul Babacan; Andrew S Brohl; Joseph Markowitz; Amod Sarnaik; Jonathan Zager; Nikhil I Khushalani; Vernon K Sondak; Jane Messina
Journal:  Pigment Cell Melanoma Res       Date:  2019-09-12       Impact factor: 4.693

5.  Liver resection and ablation for metastatic melanoma: A single center experience.

Authors:  Alexandre Doussot; Charlée Nardin; Haruyuki Takaki; Tess D Litchman; Michael I D'Angelica; William R Jarnagin; Michael A Postow; Joseph P Erinjeri; T Peter Kingham
Journal:  J Surg Oncol       Date:  2015-06-12       Impact factor: 3.454

Review 6.  Treatment Outcomes for Metastatic Melanoma of Unknown Primary in the New Era: A Single-Institution Study and Review of the Literature.

Authors:  Kierstin Utter; Chloe Goldman; Sarah A Weiss; Richard L Shapiro; Russell S Berman; Melissa Ann Wilson; Anna C Pavlick; Iman Osman
Journal:  Oncology       Date:  2017-07-27       Impact factor: 2.935

Review 7.  Long-term survival as a treatment benchmark in melanoma: latest results and clinical implications.

Authors:  Kenneth F Grossmann; Kim Margolin
Journal:  Ther Adv Med Oncol       Date:  2015-05       Impact factor: 8.168

8.  A new role of vemurafenib as a neoadjuvant treatment of axillary and brain melanoma metastases.

Authors:  Idit Melnik; Michal Lotem; Boris Yoffe
Journal:  Case Rep Oncol Med       Date:  2013-12-23

9.  Neoadjuvant treatment of melanoma: case reports and review.

Authors:  Shachar Laks; Kevin A Brueske; Eddy C Hsueh
Journal:  Exp Hematol Oncol       Date:  2013-11-08

10.  Neoadjuvant therapy for locally advanced melanoma: new strategies with targeted therapies.

Authors:  Michele La Greca; Giuseppe Grasso; Giovanna Antonelli; Alessia Erika Russo; Salvatore Bartolotta; Alessandro D'Angelo; Felice Vito Vitale; Francesco Ferraù
Journal:  Onco Targets Ther       Date:  2014-06-19       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.